Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

Published:2018 Issue:4 Volume:3 Page:e000361
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Poggio Francesca,Bruzzone Marco,Ceppi Marcello,Conte Benedetta,Martel Samuel,Maurer Christian,Tagliamento Marco,Viglietti Giulia,Del Mastro Lucia,de Azambuja Evandro,Lambertini Matteo^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer;Tung;J Clin Oncol,2016

2. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair;O’Donovan;Carcinogenesis,2010

3. PARP inhibitors in the management of breast cancer: current data and future prospects;Livraghi;BMC Med,2015

4. Synthetic lethality-a new direction in cancer-drug development;Iglehart;N Engl J Med,2009

5. Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action;Pommier;Sci Transl Med,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer;American Journal of Clinical Oncology;2024-06-20

2. PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer;Cancer Research;2024-04-18

3. Rôle des médecins dans l’adhésion des patients et des familles à la réalisation d’analyses de caractéristiques génétiques;Bulletin du Cancer;2023-10

4. The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan;Expert Review of Anticancer Therapy;2023-09-24

5. An overview of the research progress of BRCA gene mutations in breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07